 |
|
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Clin Mol Hepatol. 2024;30(3):406-420. Published online 2024 Apr 11 DOI: https://doi.org/10.3350/cmh.2024.0103
|
|
Citations to this article as recorded by
 Reply to Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Clinical and Molecular Hepatology.2024;[Epub] CrossRef Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
Junjie Chen, Tienan Feng, Qi Xu, Xiaoqi Yu, Yue Han, Demin Yu, Qiming Gong, Yuan Xue, Xinxin Zhang
Journal of Medical Virology.2024;[Epub] CrossRef
|